Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164

Nav

General Info

Geography

United States of America (USA)

Coverage type

Country

Time period covered

01/2008 - 12/2010

Data type

Scientific literature

Keywords

HIV and AIDS, Health care costs, Health care expenditures

Citation

Authors

Sax PE, Sloan CE, Schackman BR, Grant PM, Rong J, Zolopa AR, Powderly W, Losina E, Freedberg KA, Cepac US And Actg A5164 Investigators

Journal

HIV Clin Trials

Volume

Issue

Pages

248-59

Publication year

2010

Suggested citation

Sax PE, Sloan CE, Schackman BR, Grant PM, Rong J, Zolopa AR, Powderly W, Losina E, Freedberg KA, Cepac US And Actg A5164 Investigators. Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164. HIV Clin Trials. 2010; 11(5): 248-59.

DOI

10.1310/hct1105-248

PMID

21126955

GHDx Entry last modified on: Apr 10, 2023

Main menu

Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164

Nav